Hims & Hers Health (HIMS) Long-Term Debt Issuances (2021)
Hims & Hers Health's (HIMS) quarterly Long-Term Debt Issuances came in at $1.2 million in Q1 2021.
Hims & Hers Health (HIMS) Long-Term Debt Issuances (2021) Analysis & Trends
Hims & Hers Health has disclosed Long-Term Debt Issuances across 1 years of filings, most recently posting $1.2 million for Q1 2021.
- Long-Term Debt Issuances for Q1 2021 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.2 million (changed N/A YoY), and the FY2025 annual result was $970.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances came in at $1.2 million for Q1 2021 at Hims & Hers Health.
- In the past five years, Long-Term Debt Issuances ranged from a high of $1.2 million in Q1 2021 to a low of $1.2 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.19 Mn |
| Mar 31, 2021 | 1.19 Mn |